Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 5/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GLP1R | P43220 | 8/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32670212 | 1.00 | TLR2 (0.46) | TLR2MDM2TLR1KMT2AGLP1R | |
| SCHEMBL30895538 | 0.94 | TLR2 (0.49) | TLR2MDM2TLR1KMT2AGLP1R | |
| SCHEMBL30895452 | 0.94 | TLR2 (0.48) | TLR2MDM2TLR1KMT2AGLP1R | |
| SCHEMBL30895592 | 0.92 | TLR2 (0.51) | TLR2MDM2TLR1KMT2AGLP1R | |
| SCHEMBL34469052 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A | |
| SCHEMBL20561674 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A | |
| SCHEMBL30895547 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A | |
| SCHEMBL20561672 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A | |
| SCHEMBL32670249 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A | |
| SCHEMBL30895488 | 0.92 | TLR2 (0.52) | TLR2MDM2TLR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | GENMAB AS (DK) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034237-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | CSGALNACT1, SLC43A1, OSTC | TLR2 1471/4885MDM2 4297/4885TLR1 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.